Atıf İçin Kopyala
Isik M., KAYA Z., Belen F. B., Aktas A. T., TEZER H., Gursel T.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, cilt.36, sa.1, 2014 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
36
Sayı:
1
-
Basım Tarihi:
2014
-
Doi Numarası:
10.1097/mph.0000000000000079
-
Dergi Adı:
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Anahtar Kelimeler:
dipyrone, agranulocytosis, plasmacytosis, child, DRUG-INDUCED AGRANULOCYTOSIS, BLOOD DYSCRASIAS, METAMIZOLE, THROMBOCYTOSIS, TOXICITY
-
Gazi Üniversitesi Adresli:
Evet
Özet
Dipyrone or metamizole Na (Novalgin) is commonly used as an antipyretic, analgesic, and spasmolytic agent in some parts of the world; however, it is banned in developed countries because of severe side effects. Here we present a case of a 4-year-old boy who developed life-threatening agranulocytosis, anemia, and marked plasmacytosis in his bone marrow after dipyrone use for fever, which resolved with steroid therapy.